- pause slideshow
Pharmacists will “undoubtedly contribute” to cardiovascular disease prevention and diagnosis as part of primary care networks by 2021/2022, England’s chief pharmaceutical officer, Keith Ridge, has said.
The number of drug-related deaths in Scotland rose to 1,187 in 2018: a figure 27% higher than the previous year, according to data from National Records of Scotland.
Patients with type 2 diabetes mellitus and chronic kidney disease have a lower risk of kidney failure and cardiovascular events if they are treated with canagliflozin, research has confirmed.
Patients who underwent knee replacement who used an app to monitor their analgesic use had better pain control and took fewer opioids post surgery, study results show.
Concerns raised over non-medical alprazolam useSubscription
The benzodiazepine alprazolam is being obtained for non-medical use in the UK, particularly among young people, a survey has found.
Certain individuals at high risk of developing type 1 diabetes mellitis can delay progression to clinical disease by two years or more with a two-week course of teplizumab, according to a phase II study Source: Shutterstock.com
Vitamin D supplementation is not associated with a reduced risk of major cardiovascular events, a meta-analysis suggests.
People who take methadone use fewer illicit opioids when galantamine is added to their therapy, research shows.
From controversial marketing campaigns to fears that its vast dispensing facilities will quash high street pharmacy businesses, Pharmacy2U’s rise has not gone unnoticed.
As the number of antibiotics supplied through the NHS Urgent Medicine Supply Advanced Service increases, concerns are growing over its impact on antimicrobial resistance.
How to improve antifungal stewardshipSubscription